Abstract
BackgroundCAR-T cell therapy against hematological malignancies demonstrated potent therapeutic efficacy, resulting in clinical application of these treatments. On the other hand, CAR-T cell therapy against solid cancers has yet to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
